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a protocol of using the technique for established cases 
of endocarditis, in which the incidence of prosthetic 
valve endocarditis highest. 
It is logical to consider the concept of impregnating 
all valves with antibiotics to minimize prosthetic valve 
endocarditis caused by perioperative contamination. 
We suggest hat to minimize crossclamp time but to 
provide adequate short-term local antibiotic levels in 
the valve sewing ring, a commercially available valve 
with a protein-sealed sewing ring could be soaked with 
rifampicin, similar to established techniques used in 
vascular surgery. 2'3 
B. G. French, FRACS 
M. F. O'Brien, FRACS 
Department of Cardiac Surgery 
The Prince Charles Hospital 
Brisbane 4032, Australia 
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Measurement of aortic diameter 
To the Editor." 
In the October 1996 issue of the Journal, Weinert and 
colleagues 1 give an elegant account of their measurements 
of aortic diameter by means of multiplane transesopha- 
geal echoeardiography. I have no complaints whatsoever 
concerning the excellence of the techniques described, but 
I have major problems with the anatomic structures that 
are purported to be measured. Apart from the fact that 
there is no ringlike structure 2' 3 supporting the hinge- 
points of the aortic valve leaflets (the so-called "anulus"), 
if the Chicago group makes measurements as they claim, 
then it is impossible for them to quantify the fullest 
diameter of the aortic root. The reason, of course, is that 
the aortic valve possesses three sinuses and leaflets and, 
even though the sinuses are rarely completely equal, 4
measuring from the basal attachment of the noncoronary 
leaflet o the basal attachment of the right coronary leaflet 
will always produce a chord of the outflow tract. Calcula- 
tions on the basis of the aortic root being a circle shows 
that measurements of the kind proposed underestimate 
the true diameter by a factor of 10% or more. The aortic 
root, of course, is not a true circle, but these geometric 
considerations are surely worthy of at least some discus- 
sion in studies of this kind. 
Robert H. Anderson, MD, FRCPath 
Imperial College School of Medicine 
Department of Paediatrics 
National Heart and Lung Institute 
Dovehouse St. 
London SW3 6LY, United Kingdom 
REFERENCES 
1. Weinert L, Karp R, Vignon P, Bales A, Lang RM. Feasibility 
of aortic diameter measurement bymultiplane transesopha- 
geal echocardiography for preoperative s lection and prepa- 
ration of homograft aortic valves. J Thorac Cardiovasc Surg 
1996;112:954-61. 
2. Anderson RH, Devine WA, Ho SY, Smith A, McKay R. The 
myth of the aortic annulus: the anatomy of the subaortic 
outflow tract. Ann Thorac Surg 1991;52:640-6. 
3. Sutton JP III, Ho SY, Anderson RH. The forgotten i terleaf- 
let triangles: a review of the surgical anatomy of the aortic 
valve. Ann Thorac Surg 1995;59:419-27. 
4. Vollebergh FEMG, Becker AE. Minor congenital variations 
of cusp size in tricuspid aortic valves: possible link with aortic 
stenosis. Br Heart J 1977;39:1006-11. 
[Response declined] 
12/8/81128 
Neuropsychologic outcome after normothermic 
cardiopulmonary bypass 
To the Editor: 
We agree happily with virtually all of Professor Trea- 
sure's commentary following our paper. 1 Indeed, our 
agreement is already explicit in the text. We planned and 
executed a randomized controlled study within pre-recog- 
nized externally applied constraints on numbers. We 
considered the available outcome measures and con- 
cluded that none would provide sufficient power to detect 
differences of any interesting size with the numbers avail- 
able. We welcome the consensus ofexperts that has taken 
place since our study was planned and completed, but 
know that the consensus i as much a way of sharing 
responsibility for error as a guaranteed pathway to truth. 
With the information available at the time, we made a 
prospective choice of an outcome measure that should 
logically have been more sensitive than existing ones and 
declared it to be our primary measure. No pilot data were 
available on this measure that could have informed pro- 
spective power calculations. It proved, in any case, to have 
enough power to detect an interesting difference with 95% 
confidence, although we made no secret of our doubt as to 
the clinical meaning of the difference. We identified the 
further analysis as being subsidiary, to inform further 
studies on the problems of this nature. 
Nowhere did we use our results to draw inferences 
about stroke rate. Nowhere did we draw any conclusions 
about safety. Our concluding sentence remarked that our 
results, and the absence of any separate demonstration f 
benefit, provided little incentive to recommend the rou- 
tine use of normothermic systemic perfusion (instead of 
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the more established hypothermic conditions that in any 
case tend to come about by default). We completed our 
ongoing study of the effects of normothermic systemic 
perfusion on other organ systems 2-s but no longer use it 
routinely. 
The best "comic operas" need an element of tragedy. It 
often lies in the fact that the protagonists do not know 
whether and how much they agree. 
Andrew M. S. Black, FRCA a 
Inderpaul Birdi, FRCS b 
Alan J. Bryan, FRCS b 
Gianni D. Angelini, FRCS b 
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Can you top this? 
To the Editor." 
On the order of "Can you top this?," I place in the 
running for the longest recorded functioning bioprosthesis 
a Medtronic porcine bioprosthesis (Medtronic, Inc., Min- 
neapolis, Minn.), which was implanted in a Catholic priest 
on March 22, 1976, by Dr. Duvoisin of Spokane, Wash- 
ington. This bioprosthesis was replaced on December 5, 
1995, after 19 years and 258 days. At the second opera- 
tion, we found two of the three leaflets to be surprisingly 
intact, with only minimal calcification; the third leaflet had 
torn at the site of more dense calcification at the post. As 
the patient was only 52 years old at the time of this 
reoperation. I replaced the valve with an aortic homograft 
root. 
James H. Oury, MD 
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